If you are trying to quit smoking, you may be surprised to know that CBD flower can help. Not everybody would be comfortable feeling the head high caused by cannabis as often as they would smoke a cigarette. This is why non-psychoactive CBD joints are getting popular as an alternative. People visit online websites like https://itsprimo.com/ and buy pre-rolls whether it is for quitting smoking or to reduce stress and anxiety.
CBD joints provide the same benefits as cigarettes – calming down, relaxing and focusing on the breath – but without any harmful health effects associated with tobacco. Apart from being a substitute, CBD supports the struggle to quit smoking by regulating the functions and bringing back the body to homeostasis. It helps with anxiety, sleep and bring back the state of relaxation. After all, people smoke cigarettes as a way to get an outlet for their stress.
According to a study, cannabidiol helps with the symptoms of tobacco withdrawal. It can reduce the effects of nicotine withdrawal in addicted smokers. Another study found that CBD can reduce cigarette consumption and any substance affecting the endocannabinoid system can be used to treat nicotine addiction. Cannabis acts on the brain stem, a region impacted by tobacco.
CBD can help curb addiction by regulating the cannabinoid receptors in the brain. People with cravings and addiction can benefit from cannabidiol as it activates the receptors responsible for these sensations. It has been known to impact addiction pathways located in the brain. The ideal way to use this compound to quit smoking is to inhale it. Those who inhale CBD are 50 percent less likely to get a cigarette again.
CBD-rich joints are growing in popularity. This year, Wagner Dimas, a pre-roll company declared its collaboration with a leading Canadian cannabis company, Aurora to expand the manufacturing platform for pre-rolls. They will be producing 50 million jointsas compared to last year’s 5 million. The scaled platform prioritizes hemp to be able to run it in scale as a tobacco alternative. They produce herbal cigarettes that people need as an oral fixation and it has a $200 million global market.
The market may get bigger due to the FDA’s announcement regarding reduction of nicotine in cigarettes to match non-addictive amounts. Though the agency has not yet released the exact numbers, it could be about 0.5 mg per cigarette. This reduction will not only prevent over 33 million people from turning smokers but also bring down the smoking rate in the U.S. to 1.4 percent from 15 and open up the market to the new alternative of CBD pre-rolls.
A large number of CBD brands offering a variety of products have introduced CBD joints to help people adopt a healthy alternative to nicotine smoking. Users can choose from a wide range of options available at online and offline stores. These products deliver benefits like stress and anxiety reduction without any addictive or psychoactive effects. So, clearly, CBD pre-rolls are becoming the new alternative to tobacco smoking.
Those interested in investing in the legal cannabis industry can look for the U.S companies offering an opportunity. However, as marijuana remains illegal at a federal level, there is a risk for these companies. A large number of investors have, instead, opted to shift their attention to Canada which has a federally legal marijuana program and is expected to become the first nation with legal cannabis access for adults. Apart from the ability to serve its population, the Canadian cannabis industry has a large number of licensed producers involved actively in international markets such as Latin America, Europe, Israel and Australia. Such companies don’t just export but also prepare to acquire a license for the cannabis cultivation along with local investors. One of the most exciting markets for Cannabis Investment, Germany is engaged in distribution through existing pharmacies.
Health Canada is responsible for the licensing and regulation of the Canadian marijuana industry and it has granted about 90 licenses some of which are given to companies with multiple licenses. About 28 companies trade on the Canadian Securities Exchange, TSX Venture Exchange or Toronto Stock Exchange. Many of them are listed on the OTC as well as U.S listings. 15 of these companies could raise selling securities amounting to 1.17 billion CAD. The access to capital is what makes the difference between the U.S and the Canadian marijuana companies. An index for those interested in cannabis investment gives an idea of the performance of the sector. The top tier of the index consists of the biggest producers and it includes six companies generating annual sales exceeding 16 million CAD. Tier 2 includes those that generate sales but not at the same scale as the leading ones and tier 3 are the companies which have acquired the license to cultivate weed but aren’t yet permitted to sell. Overall, the sector has performed well over the last two years.
The top tier includes companies like Aphria, Aurora Cannabis, MedReleaf, Canopy Growth and CannTrust Holdings. U.S. investors willing to buy Canadian producers can open an account which allows trading Canadian securities but also makes it possible to buy the U.S. listings. Another alternative for Cannabis Investment is exchange-traded funds or ETFs. Canadian LPs currently comprise over 80 percent of the holdings of the Horizons Marijuana Life Sciences Index ETF. The decline in prices has not affected the valuations of Canadian LPs. Future sales are expected to increase with the legalization. Aurora Cannabis and Canopy Growth have market caps of about 6 billion CAD while Aphria has 2.8 billion CAD, MedReleaf 1.9 billion CAD, CanniMed 882 million CAD and CannTrust has a cap of 793 million CAD. The caps of the U.S. market are close to 20 percent lower than the Canadian cannabis industry.
Canadian marijuana companies are safer investment options than those in the U.S as it is federally legal and have performed quite well. The psychedelics industry has arrived, and its quickly gaining attention from investors, the emerging sector gained global media attention as two new psychedelic stocks went public. Magic Mushrooms Canada could be the next investment trend as it have a long lasting positive effect on emotional health.